MENU
+Compare
JAZZ
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$123.04
Change
-$0.12 (-0.10%)
Capitalization
7.43B

JAZZ Jazz Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for JAZZ with price predictions
Jan 08, 2025

JAZZ in +1.64% Uptrend, rising for three consecutive days on January 07, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where JAZZ advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

JAZZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where JAZZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on JAZZ as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JAZZ turned negative on December 30, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

JAZZ moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAZZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JAZZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.782) is normal, around the industry mean (15.212). P/E Ratio (17.416) is within average values for comparable stocks, (87.972). Projected Growth (PEG Ratio) (0.840) is also within normal values, averaging (1.839). JAZZ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (2.096) is also within normal values, averaging (258.672).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JAZZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

JAZZ is expected to report earnings to fall 12.41% to $5.79 per share on March 04

Jazz Pharmaceuticals plc JAZZ Stock Earnings Reports
Q4'24
Est.
$5.79
Q3'24
Beat
by $1.11
Q2'24
Beat
by $0.53
Q1'24
Missed
by $1.50
Q4'23
Missed
by $0.16
The last earnings report on November 06 showed earnings per share of $6.61, beating the estimate of $5.50. With 502.62K shares outstanding, the current market capitalization sits at 7.43B.
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RBLD67.521.05
+1.58%
First Trust Alerian US NextGen InfrasETF
BBCA70.230.29
+0.41%
JPMorgan BetaBuilders Canada ETF
FMAR43.160.02
+0.05%
FT Vest US Equity Buffer ETF Mar
MSTI20.24N/A
N/A
Madison Short-Term Strategic Income ETF
XHE90.12-0.58
-0.64%
SPDR® S&P Health Care Equipment ETF

JAZZ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with AMLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-0.16%
AMLX - JAZZ
43%
Loosely correlated
-1.57%
SRPT - JAZZ
35%
Loosely correlated
+0.34%
AXON - JAZZ
34%
Loosely correlated
+1.96%
VCYT - JAZZ
34%
Loosely correlated
-4.02%
INO - JAZZ
33%
Poorly correlated
-1.58%
More